Please assess the completion status of the following clinical trial:

Trial Title: Comparative Study of Micafungin (FK463) Versus Placebo as Prophylactic Antifungal Therapy in the ICU

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria~* Meets entry criteria for high risk~Exclusion Criteria~* Evidence of active invasive fungal infection~* Received more than one dose of systemic antifungal agent within 72 hours prior to first dose of study drug~* Known to be HIV positive who have CD4 count less than 500 cells/mm3~* Has life-expectancy of less than 72 hours or moribund

- Gender: ALL
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: EXPERIMENTAL): None
- 2 (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).